# Advances in 3D Bioprinting: Materials, Processes, and Emerging Applications

## TL;DR

3D bioprinting is advancing rapidly, enabling the creation of functional tissues and organs using biomaterials and living cells, with potential applications in regenerative medicine and drug testing.

## Contribution

This review provides a comprehensive overview of recent advancements in bioprinting materials, processes, and applications, emphasizing integration and future trends.

## Key findings

- Natural and synthetic biomaterials like hydrogels and PEG are being optimized for biocompatibility and printability.
- Bioprinting methods such as extrusion and inkjet are being compared for resolution, cell viability, and scalability.
- Emerging applications include organ-on-a-chip systems and patient-specific implants, supported by AI and automation trends.

## Abstract

Three-dimensional (3D) bioprinting has rapidly emerged as a transformative technology at the interface of biomedical engineering and regenerative medicine. By enabling the spatially controlled deposition of living cells, biomaterials, and bioactive molecules, it offers an unprecedented potential to fabricate functional tissues and potentially whole organs in the future. This review explores recent advances in bioprinting materials, processes, and applications, emphasizing the integration of bioinks, printing methods, and mechanical design principles that underpin tissue functionality. Natural and synthetic biomaterials such as hydrogels (e.g., collagen, alginate), polyethylene glycol (PEG), and polyesters like PLGA are evaluated in terms of biocompatibility, printability, and degradation behavior. Key bioprinting modalities, including extrusion, inkjet, and laser-assisted bioprinting, are compared based on printing resolution, cell viability, and scalability. Structural considerations such as scaffold architecture, mechanical stability, and biomimetic design are discussed in relation to native tissue mechanics and requirements. The review also surveys emerging applications in tissue engineering (e.g., bone, cartilage, skin replacements), organ-on-a-chip systems for drug testing, and patient-specific implants, while addressing persistent challenges such as standardization of biofabrication, regulatory and ethical considerations, and manufacturing scale-up. Finally, future trends, including the integration of artificial intelligence (AI) and robotic automation, multi-material and four-dimensional (4D) bioprinting, and the maturation of personalized bioprinting strategies, are highlighted as pathways toward more autonomous and clinically relevant bioprinting systems. Collectively, these developments signify a paradigm shift in how biological constructs are designed and manufactured, bridging the gap between laboratory research and clinical translation.